Instillation: Ureteral Catheter

Watch the video below for the full instructions on how to administer JELMYTO with a ureteral catheter.

Instructions for Administration

Download the JELMYTO Instructions for Administration (IFA) for a step-by-step guide for administering JELMYTO with a ureteral catheter.

Download (PDF)

Instillation: Nephrostomy Tube

Watch the video below for the full instructions on how to administer JELMYTO with a nephrostomy tube.

Nephrostomy Instructions

Download the Instruction Guide for Instillation of JELMYTO with a Nephrostomy Tube for step-by-step administration instructions.

Download (PDF)

JELMYTO is a primary treatment instilled via catheter once weekly for 6 weeks for the possibility of complete response1*

Preparation Icon

  • Reconstituted JELMYTO can be stored for up to 8 hours at room temperature
  • Can be done in an outpatient setting (fluoroscopy required)
  • General anesthesia is not required
    • Used in 37% of patients for at least one instillation during the treatment period. Local anesthesia or sedation was used at the discretion of the physician

Instillation Icon

  • JELMYTO is instilled once weekly for 6 weeks
  • 86% of patients treated with JELMYTO received the full recommended 6 doses
  • JELMYTO is instilled as a chilled liquid with a Uroject12 Syringe Lever and a 5 or 7 French ureteral catheter or via nephrostomy tube
  • JELMYTO should NOT be instilled immediately following resection or ablation

Post-Procedure Icon

  • Once it fills the renal pelvis, JELMYTO forms a gel that provides sustained exposure for up to 4 to 6 hours
  • Excreted via normal urine flow
  • Since it’s an outpatient procedure, patients can typically go home the same day
*In the Olympus Study, 58% of patients receiving Jelmyto achieved complete response.1

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088. You may also report side effects to UroGen Pharma at 1-855-987-6436.

Please click here for JELMYTO Full Prescribing Information, including the Patient Information, for additional information.

Please click here for Full Prescribing Information, Instructions for Pharmacy, and Instructions for Administration.